EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population

Marwah Al-Kaabi iD, Pooja Deshpande, Martin Firth, Rebecca Pavlos, Abha Chopra, Hamed Basiri, Jennifer Currenti, Eric Alves, Spyros Kalams, Jacques Fellay, Elizabeth Phillips, Simon Mallal und 2 weitere

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Marwah Al-Kaabi und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Human Sciences, University of Western Australia, Crawley, Australia. Hauptthemen laut MEDLINE: Aminopeptidases, HIV Infections, HIV-1, Epistasis, Genetic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Health and Medical Research Council, National Institutes of Health-funded Tennessee Center for AIDS Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A strong genetic predictor of outcome following untreated HIV-1 infection is the carriage of specific alleles of human leukocyte antigens (HLAs) that present viral epitopes to T cells. Residual variation in outcome measures may be attributed, in part, to viral adaptation to HLA-restricted T cell responses. Variants of the endoplasmic reticulum aminopeptidases (ERAPs) influence the repertoire of T cell epitopes presented by HLA alleles as they trim pathogen-derived peptide precursors to optimal lengths for antigen presentation, along with other functions unrelated to antigen presentation. We investigated whether ERAP variants influence HLA-associated HIV-1 adaptation with demonstrable effects on overall HIV-1 disease outcome. Utilizing host and viral data of 249 West Australian individuals with HIV-1 subtype B infection, we identified a novel association between two linked ERAP2 single nucleotide polymorphisms (SNPs; rs2248374 and rs2549782) with plasma HIV RNA concentration (viral load) (P adjusted = 0.0024 for both SNPs). Greater HLA-associated HIV-1 adaptation in the HIV-1 Gag gene correlated significantly with higher viral load, lower CD4 + T cell count and proportion; P = 0.0103, P = 0.0061, P = 0.0061, respectively). When considered together, there was a significant interaction between the two ERAP2 SNPs and HLA-associated HIV-1 adaptation on viral load (P = 0.0111). In a comprehensive multivariate model, addition of ERAP2 haplotypes and HLA associated adaptation as an interaction term to known HLA and CCR5 determinants and demographic factors, increased the explanatory variance of population viral load from 17.67% to 45.1% in this dataset. These effects were not replicated in publicly available datasets with comparably sized cohorts, suggesting that any true global epistasis may be dependent on specific HLA-ERAP allelic combinations. Our data raises the possibility that ERAP2 variants may shape peptide repertoires presented to HLA class I-restricted T cells to modulate the degree of viral adaptation within individuals, in turn contributing to disease variability at the population level. Analyses of other populations and experimental studies, ideally with locally derived ERAP genotyping and HLA-specific viral adaptations are needed to elucidate this further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminopeptidasesHIV InfectionsHIV-1Epistasis, GeneticPolymorphism, Single NucleotideHumansAustraliaMaleFemaleHLA AntigensViral LoadAdultMiddle Aged

Substanzen

AminopeptidasesERAP2 protein, humanHLA Antigens

Autor:innen und Institutionen

  • School of Human Sciences, University of Western Australia, Crawley, Australia.
  • Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.
  • School of Physics, Mathematics and Computing, Department of Mathematics and Statistics, University of Western Australia, Crawley, Australia.
  • Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Swiss HIV Cohort Study, Zurich, Switzerland.

ORCID-Profile: Marwah Al-Kaabi, Silvana Gaudieri

Förderung

  • NIAID NIH HHS
  • National Health and Medical Research Council
  • National Institutes of Health-funded Tennessee Center for AIDS Research
  • University of Western Australia
  • Government of Western Australia
  • BioZone
  • Australian Government Research Training Program
  • Australian Government Research Training Program Fees Offset

Zitieren

APA

Al-Kaabi, M., Deshpande, P., Firth, M., Pavlos, R., Chopra, A., Basiri, H., Currenti, J., Alves, E., Kalams, S., Fellay, J., Phillips, E., Mallal, S., John, M., & Gaudieri, S. (2024). Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012359

Vancouver

Al-Kaabi M, Deshpande P, Firth M, Pavlos R, Chopra A, Basiri H, et al. Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012359

BibTeX
@article{AlKaabi2024,
  author = {Al-Kaabi, Marwah and Deshpande, Pooja and Firth, Martin and Pavlos, Rebecca and Chopra, Abha and Basiri, Hamed and Currenti, Jennifer and Alves, Eric and Kalams, Spyros and Fellay, Jacques and Phillips, Elizabeth and Mallal, Simon and John, Mina and Gaudieri, Silvana},
  title = {Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012359}
}
Kostenlos starten →